Homeopathic Drug Product Safety, Quality, and Transparency Act

This bill creates a new regulatory framework specifically for homeopathic drugs, establishing rules distinct from those for conventional medicines. It defines homeopathic drug products as those containing only homeopathic ingredients (with no other active ingredients) and sets safety and quality standards based on the Homeopathic Pharmacopoeia of the United States. The bill requires new labeling that includes specific statements about unverified uses and removes the requirement for premarket approval of these products. It also creates a Homeopathic Drug Product Advisory Committee to advise the FDA and withdraws previous FDA guidance on homeopathic products.